Another massive acquisition by MedImmune and a new fund to uncover the next ARM lit up a vibrant October when deals in the Cambridge UK technology cluster topped $900 million.
It took the seventh month total in Business Weekly’s Cambridge Cluster Deals Digest to just over $23 billion. While MedImmune splashed the most cash, it was a home-grown innovation that had the Cambridge investment community buzzing. Cambridge University, technology superstars in the cluster and major investors joined forces to form a new company to launch a mega-million pound equity lifeline for innovative businesses.
To read the original article: Cambridge deals top $23bn in seven months | Business Weekly | Technology | Biotechnology | Business news | Cambridge and the East of England
